Stopping COPD inhalers can lead to higher risk of flare-ups for 3 months

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...
The American Journal of Managed Care

High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers

Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter ...
Monthly Prescribing Reference

Dry Powder Inhaler Containing Treprostinil Gets FDA Approval

The Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension ...
Healio

Transition to dry powder inhaled treprostinil safe, tolerable for patients with PAH

Please provide your email address to receive an email when new articles are posted on . The dry powder formulation of treprostinil studied in BREEZE is in development with a reusable breath-powered ...
Medscape

Switch to Dry Powder Asthma Inhaler 'Halves Carbon Footprint'

Switching asthma patients from a pressurised metered dose inhaler (pMDI) to a dry powder inhaler (DPI) for maintenance therapy more than halves their carbon footprint without loss of asthma control, ...
The American Journal of Managed Care

Patient Education and Proper Inhaler Technique

Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities. Jeffrey D. Dunn, PharmD, MBA: [Let’s talk about] patient perspective ...